| Market Capitalization (Millions $) |
962 |
| Shares
Outstanding (Millions) |
15 |
| Employees |
52 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-18 |
| Cash Flow (TTM) (Millions $) |
123 |
| Capital Exp. (TTM) (Millions $) |
32 |
Rayzebio Inc
Rayzebio Inc is a biotechnology company that focuses on the development and commercialization of innovative therapies for various diseases, particularly in the field of oncology. The company utilizes advanced molecular imaging technologies and biomarker analysis to identify specific targets for treatment. Rayzebio is dedicated to improving patient outcomes and has a strong pipeline of potential therapies under development. They collaborate with academic institutions and other industry partners to conduct research and clinical trials, ensuring the validity and effectiveness of their products. Overall, Rayzebio is committed to revolutionizing the approach to disease treatment and providing hope to patients and their families.
Company Address: 5505 Morehouse Drive, San Diego 92121 CA
Company Phone Number: 937-2757 Stock Exchange / Ticker: NASDAQ RYZB
|
0.21%